Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Influenza virus (Flu virus)
- Target
- Flu virus
- Molecular classification
- Virus, RNA virus, Orthomyxoviridae, Hemagglutinin, Neuraminidase, Viral polymerase complex
01
Overview
Influenza virus is a highly contagious respiratory pathogen that infects the nose, throat, and lungs. It is classified into four main types: A, B, C, and D. Types A and B are responsible for seasonal epidemics in humans. The virus's surface glycoproteins, hemagglutinin (HA) and neuraminidase (NA), are crucial for host cell entry and virion release, respectively. Transmission occurs through respiratory droplets. Prevention relies on annual vaccination and hygiene measures. Antiviral drugs like oseltamivir can reduce symptom severity if administered early.
- Other names
- Influenza A virusInfluenza B virusInfluenza C virusInfluenza D virus
02
Mechanism of action
Oseltamivir inhibits neuraminidase, preventing the release of new virions from infected cells.
03
Biological functions
Viral replicationHost cell entryViral assemblyImmune evasionInfectionTranscriptionReplication
04
Disease associations
InfectionRespiratory diseaseInfluenzaPneumoniaEpidemicPandemic
05
Safety considerations
Antiviral resistanceAdverse drug reactionsVaccine effectiveness variabilityComplications in immunocompromised individuals
06
Interacting drugs
Oseltamivir
07
Biomarkers
Viral loadAntibody titersSymptom severity
Beyond the preview
Go deeper on Influenza virus (Flu virus).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Influenza virus (Flu virus).